696 related articles for article (PubMed ID: 9783685)
21. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
22. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
[TBL] [Abstract][Full Text] [Related]
23. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
[TBL] [Abstract][Full Text] [Related]
24. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
25. Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis.
Aslan B; Serin MS; Aslan G; Kalaci A; Yanat AN; Tezcan S; Emekdas G
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):381-5. PubMed ID: 18096351
[TBL] [Abstract][Full Text] [Related]
26. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
27. Parvovirus B19 infection in Taiwanese patients with hematological disorders.
Lee YM; Tsai WH; You JY; Ing-Tiau Kuo B; Liao PT; Ho CK; Hsu HC
J Med Virol; 2003 Dec; 71(4):605-9. PubMed ID: 14556276
[TBL] [Abstract][Full Text] [Related]
28. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
29. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
30. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
32. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
Banno S; Matsumoto Y; Sugiura Y; Ueda R
Ryumachi; 1997 Aug; 37(4):581-6. PubMed ID: 9311285
[TBL] [Abstract][Full Text] [Related]
33. Persistence of parvovirus B19 in synovial fluid and bone marrow.
Nikkari S; Roivainen A; Hannonen P; Möttönen T; Luukkainen R; Yli-Jama T; Toivanen P
Ann Rheum Dis; 1995 Jul; 54(7):597-600. PubMed ID: 7668905
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report].
Stenner S; Enders G; Klee A; Eiden U; Weidner A; Gonser M
Z Geburtshilfe Neonatol; 2002; 206(3):102-6. PubMed ID: 12098826
[TBL] [Abstract][Full Text] [Related]
35. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
[TBL] [Abstract][Full Text] [Related]
36. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow.
Lundqvist A; Tolfvenstam T; Bostic J; Söderlund M; Broliden K
Scand J Infect Dis; 1999; 31(1):11-6. PubMed ID: 10381211
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens.
Bonvicini F; Manaresi E; Gallinella G; Gentilomi GA; Musiani M; Zerbini M
BJOG; 2009 May; 116(6):813-7. PubMed ID: 19432570
[TBL] [Abstract][Full Text] [Related]
38. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review.
Lowenthal EA; Wells A; Emanuel PD; Player R; Prchal JT
Am J Hematol; 1996 Mar; 51(3):207-13. PubMed ID: 8619401
[TBL] [Abstract][Full Text] [Related]
39. Human parvovirus B19 in cord blood of premature infants.
Koga M; Matsuoka T; Katayama K; Takeda K; Nakata M; Sase M; Kato H; Furukawa S
Am J Perinatol; 2001 Aug; 18(5):237-40. PubMed ID: 11552176
[TBL] [Abstract][Full Text] [Related]
40. [Parvovirus B19 among blood donors from three hospitals in Santiago, Chile].
Lévican J; Torres M; Gaggero N; Corvalán R; Gaggero A
Rev Med Chil; 2011 Feb; 139(2):143-9. PubMed ID: 21773649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
